Stocklytics Platform
Asset logo for symbol GHRS
GH Research PLC
GHRS44
$11.05arrow_drop_down5.15%-$0.60
Asset logo for symbol GHRS
GHRS44

$11.05

arrow_drop_down5.15%

Performance History

Chart placeholder
Key Stats
Open$12.12
Prev. Close$11.81
EPS-0.62
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
PE Ratio-
LOWHIGH
Day Range11.65
12.12
52 Week Range5.05
14.99
Ratios
Revenue-
EBITDA Margin %-
EPS-0.62

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Correlated Companies

Price$857.46
Perf. (24h)
arrow_drop_up1.00%$8.56
Market Cap$764.35B
Price$565.33
Perf. (24h)
arrow_drop_up0.17%$0.98
Market Cap$519.41B
Price$154.69
Perf. (24h)
arrow_drop_down0.46%-$0.73
Market Cap$374.04B
Price$125.77
Perf. (24h)
arrow_drop_up1.22%$1.52
Market Cap$314.70B

About GH Research PLC (GHRS)

GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies to treat psychiatric and neurological disorders. The company develops 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH001, an inhalable mebufotenin product candidate that has completed two Phase 1 clinical trials and Phase 1/2 clinical trial in patients with TRD. The company also develops GH002, an intravenous mebufotenin product candidate; and GH003, an intranasal mebufotenin product candidate, which are in preclinical development trials with a focus on psychiatric and neurological disorders. GH Research PLC was incorporated in 2018 and is based in Dublin, Ireland.

Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Theis Terwey M.D.
Headquarters
Dublin
Employees
32
Exchange
NASDAQ
add GH Research PLC to watchlist

Keep an eye on GH Research PLC

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is GH Research PLC's (GHRS) price per share?

The current price per share for GH Research PLC (GHRS) is $11.05. The stock has seen a price change of -$0.6 recently, indicating a -5.15% change. This reflects the stock's recent market performance and investor sentiment.

help
What is the 52-week high and low for GH Research PLC (GHRS)?

For GH Research PLC (GHRS), the 52-week high is $14.99, which is 35.66% from the current price. The 52-week low is $5.05, the current price is 118.81% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help
Is GH Research PLC (GHRS) a growth stock?

GH Research PLC (GHRS) has shown an average price growth of 0.41% over the past three years. It has received a score of 44 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying GH Research PLC as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help
What is GH Research PLC (GHRS) stock price performance year to date (YTD)?

As of the latest data, GH Research PLC (GHRS) has a year-to-date price change of 106.54%. Over the past month, the stock has experienced a price change of -4.99%. Over the last three months, the change has been 0.18%. Over the past six months, the figure is 88.89%.

help
Is GH Research PLC (GHRS) a profitable company?

GH Research PLC (GHRS) has a net income of -$35.59M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$41.22M. Furthermore, the EBITDA is -$42.01M.

help
What is the market capitalization of GH Research PLC (GHRS)?

GH Research PLC (GHRS) has a market capitalization of $614.45M. The average daily trading volume is 42.72K, indicating the stock's liquidity and investor engagement.

News

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level